| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0145-2126(01)00010-8 |
| P698 | PubMed publication ID | 11397476 |
| P2093 | author name string | A J Barrett | |
| M Kirby | |||
| T H Brümmendorf | |||
| P M Lansdorp | |||
| J J Melenhorst | |||
| P2860 | cites work | Inhibition of death receptor signals by cellular FLIP | Q24316446 |
| Extension of life-span by introduction of telomerase into normal human cells | Q24336088 | ||
| Transcription factors of the NFAT family: regulation and function | Q28237645 | ||
| Death receptors: signaling and modulation | Q28280897 | ||
| Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family | Q28285445 | ||
| An essential role for NF-kappaB in preventing TNF-alpha-induced cell death | Q29614707 | ||
| Suppression of TNF-alpha-induced apoptosis by NF-kappaB | Q29618717 | ||
| Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment | Q33652471 | ||
| The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations | Q33836041 | ||
| Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia. | Q35132088 | ||
| Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes | Q36338644 | ||
| Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions | Q36363545 | ||
| Metalloproteinase-mediated release of human Fas ligand | Q36365559 | ||
| Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. | Q36375132 | ||
| T cell receptor signals enhance susceptibility to Fas-mediated apoptosis | Q36380957 | ||
| Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity | Q36400613 | ||
| Transferrin receptor induction in mitogen-stimulated human T lymphocytes is required for DNA synthesis and cell division and is regulated by interleukin 2 | Q37614212 | ||
| Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging | Q40868941 | ||
| Absence of cancer-associated changes in human fibroblasts immortalized with telomerase | Q40978424 | ||
| Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype | Q40978432 | ||
| Induction of apoptosis in mature T cells by tumour necrosis factor | Q41293478 | ||
| Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) | Q41371079 | ||
| Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor | Q41447978 | ||
| Transcriptional regulation of the human FasL promoter-enhancer region | Q42450959 | ||
| Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. | Q42830166 | ||
| Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing | Q42951871 | ||
| Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis | Q47992184 | ||
| Evidence that human CD8+CD45RA+CD27- cells are induced by antigen and evolve through extensive rounds of division. | Q52033319 | ||
| Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. | Q55067752 | ||
| Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome | Q55670225 | ||
| Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex | Q57384656 | ||
| Fas ligand in human serum | Q71031959 | ||
| Cyclosporine A alleviates severe anaemia associated with refractory large granular lymphocytic leukaemia and chronic natural killer cell lymphocytosis | Q71099050 | ||
| T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A | Q71649955 | ||
| A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation | Q77115244 | ||
| Regulation of telomere length and telomerase in T and B cells: a mechanism for maintaining replicative potential | Q77206841 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 699-708 | |
| P577 | publication date | 2001-08-01 | |
| P1433 | published in | Leukemia Research | Q15716445 |
| P1476 | title | CD8+ T cells in large granular lymphocyte leukemia are not defective in activation- and replication-related apoptosis | |
| P478 | volume | 25 |
| Q35000627 | Alloreactivity across HLA barriers is mediated by both naïve and antigen-experienced T cells. |
| Q49276933 | Divergent roles for antigenic drive in the aetiology of primary versus dasatinib-associated CD8+ TCR-Vβ+ expansions |
| Q35914856 | Identification of human viral protein-derived ligands recognized by individual MHCI-restricted T-cell receptors |
| Q37069554 | Phenotypic differences between healthy effector CTL and leukemic LGL cells support the notion of antigen-triggered clonal transformation in T-LGL leukemia |
| Q46921934 | T-large granular lymphocyte leukaemia. An important differential diagnosis to Felty's syndrome |
| Q37567637 | The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders |
| Q35226245 | The spectrum of large granular lymphocyte leukemia and Felty's syndrome |
Search more.